Physician profile
Anthony George
NPI 1225032014
$8,848.62
in general payments reported to CMS, 2019-2025
11 companies · $66.44 in 2025
The $66.44 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,123 · 2020: $386 · 2022: $66.01 · 2023: $18.31 · 2024: $189 · 2025: $66.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,524.53 | 2019-2024 | |
| Davol INC. | $83.91 | 2020-2023 | Phasix Mesh |
| Tela Bio, INC. | $55.36 | 2019 | |
| Boston Scientific Corporation | $46.97 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $34.53 | 2025 | Exparel |
| Stryker Corporation | $25.68 | 2024 | 1788 |
| Merit Medical Systems INC | $19.25 | 2024 | Savi Scout |
| Smith+Nephew, INC. | $17.43 | 2025 | Renasys Touch |
| Solventum Corporation | $14.48 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Ethicon US, LLC | $13.49 | 2019 | |
| W. L. Gore & Associates, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.